Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation. (2018)

First Author: Chatterjee S
Attributed to:  Antioxidant defence in adrenocortical cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/eje-18-0042

PubMed Identifier: 29500309

Publication URI: http://europepmc.org/abstract/MED/29500309

Type: Journal Article/Review

Volume: 178

Parent Publication: European journal of endocrinology

Issue: 5

ISSN: 0804-4643